2024
McClurg, U. L. (2024). Conference accessibility should be a universal concern.. Nature cell biology, 26(3), 309. doi:10.1038/s41556-024-01346-6DOI: 10.1038/s41556-024-01346-6
2023
Chalmers, S. B., Madgwick, S., Lloyd-Lewis, B., McClurg, U. L., Elias, S., Andersen, P., . . . Davis, F. M. (2023). Towards inclusive and sustainable scientific meetings.. Nature cell biology, 25(11), 1557-1560. doi:10.1038/s41556-023-01222-9DOI: 10.1038/s41556-023-01222-9
Scott, E., Archer Goode, E., Garnham, R., Hodgson, K., Orozco-Moreno, M., Turner, H., . . . Munkley, J. (2023). ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.. The Journal of pathology. doi:10.1002/path.6152DOI: 10.1002/path.6152
Zhang, J., Hu, Z., Chung, H. H., Tian, Y., Lau, K. W., Ser, Z., . . . Tee, W. -W. (2023). Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis.. Nature communications, 14(1), 2439. doi:10.1038/s41467-023-38132-1DOI: 10.1038/s41467-023-38132-1
Scott, E., Hodgson, K., Calle, B., Turner, H., Cheung, K., Bermudez, A., . . . Munkley, J. (2023). Upregulation of GALNT7 in prostate cancer modifies <i>O</i>-glycosylation and promotes tumour growth. ONCOGENE, 42(12), 926-937. doi:10.1038/s41388-023-02604-xDOI: 10.1038/s41388-023-02604-x
Cancer and meiotic gene expression: Two sides of the same coin? (Chapter)
Sou, I. F., Hamer, G., Tee, W. -W., Vader, G., & McClurg, U. L. (2023). Cancer and meiotic gene expression: Two sides of the same coin?. In Unknown Book (Vol. 151, pp. 43-68). doi:10.1016/bs.ctdb.2022.06.002DOI: 10.1016/bs.ctdb.2022.06.002
2022
2021
Sandhu, S., Sou, I. F., Hunter, J. E., Salmon, L., Wilson, C. L., Perkins, N. D., . . . McClurg, U. L. (2021). Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12. COMMUNICATIONS BIOLOGY, 4(1). doi:10.1038/s42003-021-02887-4DOI: 10.1038/s42003-021-02887-4
Sou, I. F., Pryce, R. M., Tee, W. -W., & McClurg, U. L. (2021). Meiosis initiation: a story of two sexes in all creatures great and small. BIOCHEMICAL JOURNAL, 478(20), 3791-3805. doi:10.1042/BCJ20210412DOI: 10.1042/bcj20210412
2020
Prendergast, L., McClurg, U. L., Hristova, R., Berlinguer-Palmini, R., Greener, S., Veitch, K., . . . Papamichos-Chronakis, M. (2020). Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability. Nature Communications, 11. doi:10.1038/s41467-020-18306-xDOI: 10.1038/s41467-020-18306-x
Metabolism of multiple glycosaminoglycans by <i>Bacteroides thetaiotaomicron</i> is orchestrated by a versatile core genetic locus (vol 11, 646, 2020) (Journal article)
Ndeh, D., Basle, A., Strahl, H., Yates, E. A., McClurgg, U. L., Henrissat, B., . . . Cartmell, A. (2020). Metabolism of multiple glycosaminoglycans by <i>Bacteroides thetaiotaomicron</i> is orchestrated by a versatile core genetic locus (vol 11, 646, 2020). NATURE COMMUNICATIONS, 11(1). doi:10.1038/s41467-020-18097-1DOI: 10.1038/s41467-020-18097-1
Ndeh, D., Baslé, A., Strahl, H., Yates, E. A., McClurgg, U. L., Henrissat, B., . . . Cartmell, A. (2020). Metabolism of multiple glycosaminoglycans by Bacteroides thetaiotaomicron is orchestrated by a versatile core genetic locus. Nature Communications, 11. doi:10.1038/s41467-020-14509-4DOI: 10.1038/s41467-020-14509-4
2019
Sandhu, S., Salmon, L. J., Hunter, J. E., Wilson, C. L., Perkins, N. D., Hunter, N., . . . McClurg, U. L. (2019). A pseudo-meiotic centrosomal function of TEX12 in cancer. doi:10.1101/509869DOI: 10.1101/509869
2018
McClurg, U. L., McCracken, S. R., Butler, L., Riabowol, K. T., & Binda, O. (2018). <i>Ex vivo</i> Culture and Lentiviral Transduction of Benign Prostatic Hyperplasia (BPH) Samples. BIO-PROTOCOL, 8(21). doi:10.21769/BioProtoc.3075DOI: 10.21769/BioProtoc.3075
McClurg, U. L., Azizyan, M., Dransfield, D. T., Namdev, N., Chit, N. C. T. H., Nakjang, S., & Robson, C. N. (2018). The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival. Oncotarget, 9(38), 24992-25007. doi:10.18632/oncotarget.25167DOI: 10.18632/oncotarget.25167
McClurg, U. L., Chit, N. C. T. H., Azizyan, M., Edwards, J., Nabbi, A., Riabowol, K. T., . . . Robson, C. N. (2018). Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12. ONCOGENE, 37(34), 4679-4691. doi:10.1038/s41388-018-0283-3DOI: 10.1038/s41388-018-0283-3
McClurg, U. L., Nabbi, A., Ricordel, C., Korolchuk, S., McCracken, S., Heer, R., . . . Binda, O. (2018). Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein. British Journal of Cancer, 118, 713-726. doi:10.1038/bjc.2017.447DOI: 10.1038/bjc.2017.447
2017
Munkley, J., McClurg, U. L., Livermore, K. E., Ehrmann, I., Knight, B., Mccullagh, P., . . . Elliott, D. J. (2017). The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration. SCIENTIFIC REPORTS, 7. doi:10.1038/s41598-017-05489-5DOI: 10.1038/s41598-017-05489-5
Nabbi, A., McClurg, U. L., Thalappilly, S., Almami, A., Mobahat, M., Bismar, T. A., . . . Riabowol, K. T. (2017). ING3 promotes prostate cancer growth by activating the androgen receptor. BMC MEDICINE, 15. doi:10.1186/s12916-017-0854-0DOI: 10.1186/s12916-017-0854-0
McClurg, U. L., Cork, D. M. W., Darby, S., Ryan-Munden, C. A., Nakjang, S., Cortes, L. M., . . . Robson, C. N. (2017). Identification of a novel K311 ubiquitination site critical for androgen receptor transcriptional activity. NUCLEIC ACIDS RESEARCH, 45(04), 1793-1804. doi:10.1093/nar/gkw1162DOI: 10.1093/nar/gkw1162
2016
A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival (Journal article)
McClurg, U., Dransfield, D., Namdev, N., Jacoby, D., Chit, N., Nakjang, S., . . . Robson, C. (2016). A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival. European Journal of Cancer, 69, S25. doi:10.1016/s0959-8049(16)32654-5DOI: 10.1016/s0959-8049(16)32654-5
Logan, I. R., McClurg, U. L., Jones, D. L., O'Neill, D. J., Shaheen, F. S., Lunec, J., . . . Robson, C. N. (2016). Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells. ONCOTARGET, 7(46), 74724-74733. doi:10.18632/oncotarget.12542DOI: 10.18632/oncotarget.12542
The deubiquitinating enzyme USP12 controls prostate cancer cell survival by regulating the AR-AKT-p53 signalling network (Journal article)
McClurg, U. L., Chit, N. C. T. H., Nakjang, S., Edwards, J., McCracken, S. R., & Robson, C. N. (n.d.). The deubiquitinating enzyme USP12 controls prostate cancer cell survival by regulating the AR-AKT-p53 signalling network. Endocrine Abstracts. doi:10.1530/endoabs.42.p9DOI: 10.1530/endoabs.42.p9
Kim, S., Natesan, S., Cornilescu, G., Carlson, S., Tonelli, M., McClurg, U. L., . . . Glass, K. C. (2016). Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3. JOURNAL OF BIOLOGICAL CHEMISTRY, 291(35), 18326-18341. doi:10.1074/jbc.M115.690651DOI: 10.1074/jbc.M115.690651
2015
McClurg, U. L., Harle, V. J., Nabbi, A., Batalha-Pereira, A., Walker, S., Coffey, K., . . . Robson, C. N. (2015). Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer. ONCOTARGET, 6(35), 37724-37736. doi:10.18632/oncotarget.6075DOI: 10.18632/oncotarget.6075
Munkley, J., Livermore, K. E., McClurg, U. L., Kalna, G., Knight, B., McCullagh, P., . . . Elliott, D. J. (2015). The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells.. Oncoscience, 2(9), 755-764. doi:10.18632/oncoscience.243DOI: 10.18632/oncoscience.243
McClurg, U. L., & Robson, C. N. (2015). Deubiquitinating enzymes as oncotargets. ONCOTARGET, 6(12), 9657-9668. doi:10.18632/oncotarget.3922DOI: 10.18632/oncotarget.3922
Epithelial cell ADAM17 activation by <i>Helicobacter pylori</i>: role of ADAM17 <i>C</i>-terminus and Threonine-735 phosphorylation (Journal article)
McClurg, U. L., Danjo, K., King, H. O., Scott, G. B., Robinson, P. A., & Crabtree, J. E. (2015). Epithelial cell ADAM17 activation by <i>Helicobacter pylori</i>: role of ADAM17 <i>C</i>-terminus and Threonine-735 phosphorylation. MICROBES AND INFECTION, 17(3), 205-214. doi:10.1016/j.micinf.2014.11.011DOI: 10.1016/j.micinf.2014.11.011
2014
McClurg, U. L., Summerscales, E. E., Harle, V. J., Gaughan, L., & Robson, C. N. (2014). Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway. ONCOTARGET, 5(16), 7081-7092. doi:10.18632/oncotarget.2162DOI: 10.18632/oncotarget.2162
Literature Search and Review (Journal article)
Davis, M. I., Lea, W., Simeonov, A., & Auld, D. (2014). Literature Search and Review. ASSAY and Drug Development Technologies, 12(2), 101-109. doi:10.1089/adt.2014.1202.lrDOI: 10.1089/adt.2014.1202.lr
Two plasmid-encoded genes of enteropathogenic <i>Escherichia coli</i> strain K798 promote invasion and survival within HEp-2 cells (Journal article)
Burska, U. L., & Fletcher, J. N. (2014). Two plasmid-encoded genes of enteropathogenic <i>Escherichia coli</i> strain K798 promote invasion and survival within HEp-2 cells. APMIS, 122(10), 922-930. doi:10.1111/apm.12234DOI: 10.1111/apm.12234
2013
Burska, U. L., Harle, V. J., Coffey, K., Darby, S., Ramsey, H., O'Neill, D., . . . Robson, C. N. (2013). Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor. JOURNAL OF BIOLOGICAL CHEMISTRY, 288(45), 32641-32650. doi:10.1074/jbc.M113.485912DOI: 10.1074/jbc.M113.485912